142 related articles for article (PubMed ID: 29953583)
21. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation.
Rombout A; Lust S; Offner F; Naessens E; Verhasselt B; Philippé J
Br J Cancer; 2016 Mar; 114(6):704-12. PubMed ID: 26924423
[TBL] [Abstract][Full Text] [Related]
22. Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia.
Nikitin EA; Malakho SG; Biderman BV; Baranova AV; Lorie YY; Shevelev AY; Peklo MM; Vlasik TN; Moskalev EA; Zingerman BV; Vorob'ev IA; Poltaraus AB; Sudarikov AB; Vorobjev AI
Leuk Lymphoma; 2007 May; 48(5):912-22. PubMed ID: 17487735
[TBL] [Abstract][Full Text] [Related]
23. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression.
Prieto D; Oppezzo P
Molecules; 2017 Dec; 22(12):. PubMed ID: 29206143
[TBL] [Abstract][Full Text] [Related]
25. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.
MacIntyre DA; Jiménez B; Lewintre EJ; Martín CR; Schäfer H; Ballesteros CG; Mayans JR; Spraul M; García-Conde J; Pineda-Lucena A
Leukemia; 2010 Apr; 24(4):788-97. PubMed ID: 20090781
[TBL] [Abstract][Full Text] [Related]
26. Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.
Palma M; Parker A; Hojjat-Farsangi M; Forster J; Kokhaei P; Hansson L; Osterborg A; Mellstedt H
Exp Hematol; 2013 Jul; 41(7):615-26. PubMed ID: 23548418
[TBL] [Abstract][Full Text] [Related]
27. ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia.
Catherwood MA; Matthews C; Niblock R; Dobbin E; Morris TC; Alexander HD
Eur J Haematol; 2006 Apr; 76(4):294-8. PubMed ID: 16519700
[TBL] [Abstract][Full Text] [Related]
28. Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.
Pede V; Rombout A; Vermeire J; Naessens E; Vanderstraeten H; Philippé J; Verhasselt B
Br J Haematol; 2013 Dec; 163(5):621-30. PubMed ID: 24219331
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
30. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.
Baer C; Dicker F; Kern W; Haferlach T; Haferlach C
Leukemia; 2017 Jun; 31(6):1355-1362. PubMed ID: 27840426
[TBL] [Abstract][Full Text] [Related]
31. SOX11 expression in chronic lymphocytic leukemia correlates with adverse prognostic markers.
Roisman A; Stanganelli C; Nagore VP; Richardson GV; Scassa ME; Bezares RF; Cabrejo M; Slavutsky I
Tumour Biol; 2015 Jun; 36(6):4433-40. PubMed ID: 25608839
[TBL] [Abstract][Full Text] [Related]
32. Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.
Humphries LA; Godbersen JC; Danilova OV; Kaur P; Christensen BC; Danilov AV
Br J Haematol; 2013 Dec; 163(5):590-602. PubMed ID: 24117128
[TBL] [Abstract][Full Text] [Related]
33. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein lipase: a new prognostic factor in chronic lymphocytic leukaemia.
Hartman ML; Kilianska ZM
Contemp Oncol (Pozn); 2012; 16(6):474-9. PubMed ID: 23788932
[TBL] [Abstract][Full Text] [Related]
35. GALNT11 as a new molecular marker in chronic lymphocytic leukemia.
Libisch MG; Casás M; Chiribao M; Moreno P; Cayota A; Osinaga E; Oppezzo P; Robello C
Gene; 2014 Jan; 533(1):270-9. PubMed ID: 24076351
[TBL] [Abstract][Full Text] [Related]
36. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.
Rombout A; Verhasselt B; Philippé J
Eur J Haematol; 2016 Nov; 97(5):409-415. PubMed ID: 27504855
[TBL] [Abstract][Full Text] [Related]
38. Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment.
Daugaard I; Hussmann D; Kristensen L; Kristensen T; Kjeldsen TE; Nyvold CG; Larsen TS; Møller MB; Hansen LL; Wojdacz TK
Epigenomics; 2018 Sep; 10(9):1155-1166. PubMed ID: 30182737
[TBL] [Abstract][Full Text] [Related]
39. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia.
Ferrer A; Ollila J; Tobin G; Nagy B; Thunberg U; Aalto Y; Vihinen M; Vilpo J; Rosenquist R; Knuutila S
Cancer Genet Cytogenet; 2004 Aug; 153(1):69-72. PubMed ID: 15325098
[TBL] [Abstract][Full Text] [Related]
40. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.
Orchard JA; Ibbotson RE; Davis Z; Wiestner A; Rosenwald A; Thomas PW; Hamblin TJ; Staudt LM; Oscier DG
Lancet; 2004 Jan; 363(9403):105-11. PubMed ID: 14726163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
